首页> 外文学位 >Localization of ligand-binding exosites in the catalytic domain of FXIa and determination of the roles of calcium and the heavy chain of FXIa in fix activation by FXIa.
【24h】

Localization of ligand-binding exosites in the catalytic domain of FXIa and determination of the roles of calcium and the heavy chain of FXIa in fix activation by FXIa.

机译:FXIa催化域中配体结合异位沸石的定位以及FXIa固定激活中钙和FXIa重链的作用测定。

获取原文
获取原文并翻译 | 示例

摘要

Coagulation factor XI (FXI) is a plasma zymogen that is activated to FXIa, the catalytic domain of which contains exosites that interact with its normal macromolecular substrate (FIX), and its major regulatory inhibitor (protease nexin-2 kunitz protease inhibitor, PN2KPI). To localize the catalytic domain residues involved in active site architecture and in various ligand-binding exosites, we aligned the sequence of the FXI catalytic domain with that of the prekallikrein (PK) catalytic domain which is highly homologous (64% identity) in sequence, but functionally very different from FXI. Six distinct regions (R1-R6) of dissimilarity between the two proteins were identified as possible candidates for FXIa-specific ligand binding exosites. FXI/PK chimeric proteins (FXI-R1, FXI-R2, FXI-R3, FXI-R4, FXI-R5, or FXI-R6) containing substitutions with PK residues within the six regions were prepared and characterized. FXIa-R1, R2, R3 displayed enhanced proteolysis after activation by factor XIIa suggesting that the residues within R1, R2 and R3 regions may be important to maintain proper folding of the enzyme. Comparisons of amidolytic assays vs. activated partial thromboplastin time assays showed similar activities for all chimeras except FXI-R6, which displayed 60% of the normal amidolytic activity but only 28% of clotting activity suggesting the possibility that the R6 region (autolysis loop) of FXIa may comprise an exosite involved in the interaction with its macromolecular substrate FIX. This hypothesis was further confirmed by examinations of FIX-activation showing that FIX-activation by FXIa-R6 was significantly impaired compared with that achieved by FXIawt. Although FXI-R5 and FXI-R6 were defective (50-60%) in amidolytic assays, these chimeras were very similar to FXIawt in heparin and high molecular weight kininogen binding assays, suggesting that residues within the R5 and R6 regions are involved in active-site architecture. These chimeras were further investigated to determine whether any of them had acquired kallikrein activity. After activation all except FXIa-R4 showed insignificant activity in assays utilizing a kallikrein-specific chromogenic substrate. FXIa-R4 displayed 87% of the activity of kallikrein using the kallikrein-specific substrate but only 4% of the activity of FXIa wt using the FXIa chromogenic substrate. Moreover the cleavage pattern and cleavage rate of high molecular weight kininogen utilizing FXIa-R4 as the enzyme were similar to those achieved with kallikrein but not with FXIawt. Therefore substitutions in the R4 region of FXI with the corresponding residues of PK resulted in loss of activity for the FXIa substrates and gain of activity for the kallikrein substrates suggesting that the R4 region (99-loop) of FXIa plays a role in determining the substrate specificity.;To determine the roles of calcium and the two FIX-binding exosites within the heavy and light chains of FXIa in the cleavages of the two scissile bonds of FIX respectively, FXI-R145A (in which only the cleavage at R180 -V181 available) and FIX-R180A (in which only the cleavage at R145-A146 available) were prepared. The cleavage rate at R145-A146 of FIX-R180A in the absence of calcium was slower than in the presence of calcium ions. The cleavage rate at R180-V181 of FIX-R145A without the prior cleavage at R145 by FXIa in the presence of calcium ions was much slower than that of wild-type FIX indicating that the efficient cleavage at R180 -V181 is facilitated by the prior cleavage at R 145-A146. The scissile bond R180-V 181 of FIX-R145A was hardly cleaved by FXIa in the absence of calcium ions or the heavy chain of FXIa from which we conclude that both calcium and the heavy chain of FXIa are required for efficient cleavage at R180 -V181 of FIX. Based on these results, we propose a model of the mechanism of FIX-activation by FXIa: When FIX is activated by FXIa in the presence of calcium ions, FIX binds to both heavy and light chains of FXIa to bring the two scissile bonds of FIX, R145-A 146 and R180-V181, close enough to be cleaved almost simultaneously for FIXa generation. When FIX is activated by FXIa in the absence of calcium ions or by FXIa-LC lacking the heavy chain of FXIa, FIX binds only to the light chain of FXIa to facilitate cleavage of the first scissile bond (R145-A146) producing the inactive intermediate FIXalpha whereas the second cleavage at R 180-V181 is slow resulting in the accumulation of FIXalpha. (Abstract shortened by UMI.)
机译:凝血因子XI(FXI)是一种被激活为FXIa的血浆酶原,其催化域包含与其正常的大分子底物(FIX)及其主要调节抑制剂(蛋白酶nexin-2 kunitz蛋白酶抑制剂PN2KPI)相互作用的异岩石。 。为了定位参与活性位点结构和各种配体结合外泌体的催化结构域残基,我们将FXI催化结构域的序列与前激肽释放酶(PK)催化结构域的序列进行了比对,该序列的序列高度同源(同一性为64%),但功能上与FXI有很大不同。两种蛋白质之间六个不同的不同区域(R1-R6)被确定为FXIa特异性配体结合外生石的可能候选对象。制备并表征了在六个区域内含有被PK残基取代的FXI / PK嵌合蛋白(FXI-R1,FXI-R2,FXI-R3,FXI-R4,FXI-R5或FXI-R6)。 FXIa-R1,R2,R3在被因子XIIa激活后显示出增强的蛋白水解作用,表明R1,R2和R3区域内的残基可能对维持酶的正确折叠很重要。酰胺分解试验与活化部分凝血活酶时间分析的比较显示,除FXI-R6外,所有嵌合体均具有相似的活性,FXI-R6表现出60%的正常酰胺分解活性,但凝结活性仅为28%,表明可能是RXI区域(自溶环) FXIa可包含参与与其大分子底物FIX相互作用的外位点。通过检查FIX激活进一步证实了这一假设,结果表明与FXIawt相比,FXIa-R6的FIX激活受到显着损害。尽管FXI-R5和FXI-R6在酰胺分解测定中存在缺陷(50-60%),但这些嵌合体在肝素和高分子量激肽原结合测定中与FXIawt非常相似,这表明R5和R6区域内的残基参与了活性站点架构。进一步研究了这些嵌合体,以确定它们中的任何一个是否都具有激肽释放酶活性。激活后,除FXIa-R4以外的所有其他蛋白在使用激肽释放酶特异性生色底物的测定中均显示不重要的活性。使用激肽释放酶特异性底物,FXIa-R4显示出激肽释放酶的活性的87%,但使用FXIa生色底物,则仅显示FXIa wt活性的4%。而且,利用FXIa-R4作为酶的高分子量激肽原的裂解模式和裂解速率与激肽释放酶所达到的裂解模式和裂解速率相似,但与FXIawt的裂解模式和裂解速率相似。因此,用相应的PK残基取代FXI的R4区域会导致FXIa底物的活性降低,而激肽释放酶底物的活性增加,这表明FXIa的R4区域(99-环)在确定底物方面发挥了作用为了确定钙和FXIa重链和轻链中的两个FIX结合异岩分别在FIX的两个易裂键的裂解中的作用,FXI-R145A(其中仅在R180 -V181处可裂解) )和FIX-R180A(仅在R145-A146处可切割)。在不存在钙的情况下,FIX-R180A在R145-A146处的裂解速率要比在存在钙离子的情况下慢。 FIX-R145A在R180-V181处的裂解速率没有在钙离子存在下被FXIa事先在R145处裂解的速率比野生型FIX慢得多,这表明先前的裂解有助于在R180 -V181处的有效裂解。在R 145-A146。在不存在钙离子或FXIa重链的情况下,FIX-R145A的易裂键R180-V 181几乎不被FXIa裂解,由此我们得出结论,钙和FXIa重链均需要在R180 -V181上有效裂解。 FIX。根据这些结果,我们提出了一种由FXIa激活FIX的机制的模型:当FIX在钙离子存在下被FXIa激活时,FIX会与FXIa的重链和轻链结合,从而使FIX的两个易裂键,R145-A 146和R180-V181的距离足够近,几乎可以同时切割以产生FIXa。当FIX在不存在钙离子的情况下被FXIa激活,或者被缺乏FXIa重链的FXIa-LC激活时,FIX仅与FXIa的轻链结合,从而促进第一个易裂键(R145-A146)的裂解,从而产生非活性中间体FIXalpha,而在R 180-V181处的第二次切割缓慢,导致FIXalpha的积累。 (摘要由UMI缩短。)

著录项

  • 作者

    Su, Ya-Chi.;

  • 作者单位

    Temple University.;

  • 授予单位 Temple University.;
  • 学科 Chemistry Biochemistry.;Health Sciences Medicine and Surgery.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 124 p.
  • 总页数 124
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号